Quality & complianceOfficial

Class II drug recall: Lidocaine Ointment USP (Sun Pharma /Taro)

🇺🇸 FDA enforcement report · Wed 23 Sep 2026

Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH). Recall D-0848-2026; status Ongoing; distribution: Nationwide in the USA.

Official source: FDA enforcement report ↗

Brief written by VigiEye from the company's press release. Claims are the company's own. AI-assisted; check the source before acting.

More Quality & compliance All →